Kim, H., Park, J., & Kim, J. (2022). Targeted Protein Degradation to Overcome Resistance in Cancer Therapies: PROTAC and N-Degron Pathway. MDPI AG.
Chicago Style (17th ed.) CitationKim, Hanbyeol, Jeongbae Park, and Jeong-Mok Kim. Targeted Protein Degradation to Overcome Resistance in Cancer Therapies: PROTAC and N-Degron Pathway. MDPI AG, 2022.
MLA (9th ed.) CitationKim, Hanbyeol, et al. Targeted Protein Degradation to Overcome Resistance in Cancer Therapies: PROTAC and N-Degron Pathway. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.